KOSDAQApparel & Living003800

AceBed

₩30,450▼ 0.33%2026-11-18 close
Market Cap
₩337.7B
Turnover
₩38,390,225
Volume
1.3K
Shares out.
11.1M
PER
6.4×
PBR
0.4×
EPS
₩4,951
Dividend Yield
—

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Prices as of the 2026-11-18 close

01

Report overview

AceBed: Premium Mix Supports Sales, Profit Trend Under Review

With beds accounting for 89.3% of first-half 2026 sales, AceBed's operating profit fell in 2025 after its 2024 rebound and dropped again in Q3 2026, making SG&A and raw material costs the next items to watch.

  1. 1

    Beds generated KRW 151.6 billion in first-half 2026 sales, up 7.2% year on year and 89.3% of total revenue.

  2. 2

    Annual operating profit moved from KRW 66.2 billion in 2024 (up 16.1%) to KRW 54.1 billion in 2025 (down 18.3%).

  3. 3

    Quarterly sales peaked at KRW 85 billion in Q1 2026 and then fell in Q2 and Q3, while Q3 operating profit was KRW 9.82 billion, down 40.9% from the prior quarter.

  4. 4

    In Q2 2026, selling and administrative expenses rose 17.5% and raw material prices climbed, so operating profit fell 1.7% year on year despite sales growth (per half-year report coverage).

  5. 5

    At year-end 2025 the debt ratio was 9.3%, with total equity of KRW 748.4 billion and total liabilities of KRW 70 billion, a light debt load.

02

Business structure

AceBed manufactures and sells beds and furniture and also runs real estate sales and leasing. Of first-half 2026 consolidated sales of KRW 169.8 billion, bed sales reached KRW 151.6 billion, up 7.2% from the same period a year earlier, accounting for 89.3% of total revenue.

The remaining share of revenue comes from the furniture and other segments. The average domestic selling price of beds rose 4.2% to KRW 2.014 million in first-half 2026 from KRW 1.932 million a year earlier, which the company attributed to product mix improvement and pricing policy.

On product mix, the premium line is central: the share of top-tier mattresses, including Royal Ace, expanded to 4.2% of sales in 2024. The company said more customers are buying bed frames and mattresses as a set from the same brand, which improved overall brand profitability.

In distribution, the ACE SQUARE experience store format is the core, with 54 locations as of early 2025, and 10 new or renovated stores opened in 2025. The pricing stance has been conservative: over seven years to 2024 the company raised prices only twice, while major competitors raised prices over the same period.

Competitively, AceBed is described as a leader among domestic bed brands. Other listed furniture and bedding companies in the same sector, such as Fursys and Zinus, have different business structures, so direct comparison is limited.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩79.9B₩12.3B15.4%
2025Q4₩79.5B₩12.8B16.1%
2026Q1₩85B₩12.8B15.1%
2026Q2₩84.8B₩16.6B19.6%
2026Q3₩78.9B₩9.8B12.5%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩346.2B₩65.3B₩54.4B18.9%8.9%11.5%
2023₩306.4B₩57B₩51.4B18.6%7.9%9.8%
2024₩326B₩66.2B₩65.9B20.3%9.3%10.7%
2025₩317.3B₩54.1B₩56B17.0%7.5%9.3%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-13

04

Earnings analysis

Annual sales were KRW 346.2 billion in 2022, KRW 306.4 billion in 2023, KRW 326 billion in 2024 and KRW 317.3 billion in 2025; the largest year in 2022–2025 was 2022 and the smallest was 2023. Sales fell 11.5% in 2023, rose 6.4% in 2024 and fell 2.7% in 2025.

Operating profit went from KRW 65.3 billion in 2022 to KRW 57 billion in 2023 (down 12.7%), recovered to KRW 66.2 billion in 2024 (up 16.1%), and dropped to KRW 54.1 billion in 2025 (down 18.3%). By operating profit, 2024 was the largest year and 2025 the smallest.

Operating margin was 18.9% in 2022, 18.6% in 2023, 20.3% in 2024 and 17.0% in 2025.

Profit attributable to owners of the parent was KRW 54.4 billion in 2022, KRW 51.4 billion in 2023, KRW 65.9 billion in 2024 (up 28.2%) and KRW 56 billion in 2025 (down 15.1%); net income was disclosed at the same amount as parent profit in each year.

The 2024 rebound was attributed by the company to premium product lines including Royal Ace, expansion of the ACE SQUARE experience stores, and diversified brand communication, while the 2023 decline was linked to weak moving and interior demand.

Operating cash flow was KRW 50.7 billion in 2022, KRW 61.9 billion in 2023, KRW 75.1 billion in 2024 and KRW 51.5 billion in 2025, and the year-end 2025 debt ratio was 9.3% on total liabilities of KRW 70 billion and total equity of KRW 748.4 billion.

Quarterly sales went from KRW 79.9 billion in Q3 2025 and KRW 79.5 billion in Q4 2025 (down 0.5% quarter on quarter) to a peak of KRW 85 billion in Q1 2026 (up 7.0%), then KRW 84.8 billion in Q2 (down 0.3%) and KRW 78.9 billion in Q3 (down 7.0% quarter on quarter and down 1.3% year on year), declining for two consecutive quarters.

Quarterly operating profit was KRW 12.3 billion in Q3 2025, KRW 12.8 billion in Q4 2025 and KRW 12.8 billion in Q1 2026, rose to KRW 16.6 billion in Q2 2026 (up 29.8%), then fell to KRW 9.82 billion in Q3 2026 (down 40.9% quarter on quarter and down 20.1% year on year).

Half-year report coverage said that although average bed selling prices rose, selling and administrative expenses climbed 17.5% and raw material prices increased, so Q2 operating profit fell 1.7% year on year.

Parent profit was KRW 15 billion in Q1 2026, KRW 22.4 billion in Q2 and KRW 2.97 billion in Q3, and the last four quarters (Q4 2025 to Q3 2026) total KRW 52.3 billion. The detailed cause of the Q3 cost structure change should be checked in the next annual report's SG&A and cost lines.

05

Industry analysis

Beds are a high-involvement, infrequently purchased product, so brand trust and in-store experience influence buying decisions. During 2023, when sales and operating profit declined, weak moving and interior demand was cited as an external factor.

The company said premium mattress demand from newlywed couples has grown since 2024, and that the all-in-room trend, in which people live work and hobby activities on the bed, is lifting demand for high-end products.

Unlike major competitors that raised prices over the past two years, AceBed has held prices, which is viewed as a differentiator. The 4.2% rise in average domestic bed selling prices in first-half 2026 was attributed to product mix improvement and pricing policy.

In cycle terms, operating profit rebounded in 2024, fell in 2025 on an annual basis, and has declined for two consecutive quarters since the Q1 2026 sales peak, so a recovery in end demand is not yet clearly visible in the data.

Higher raw material prices are a shared industry cost pressure and were reported as a constraint on AceBed's Q2 2026 profitability. AceBed is described as a leading domestic bed brand, while Fursys and Zinus in the same sector have different business structures, so direct comparison is limited.

06

Outlook

According to the half-year report, first-half 2026 research and development spending was KRW 931.43 million, about 0.56% of sales, and the company is developing new products such as more durable mattresses and improving manufacturing processes.

In the second half of 2025, new product sales and renovated store expansion were cited as factors behind a gradual recovery. On pricing, the average domestic bed selling price rose 4.2% to KRW 2.014 million in first-half 2026, which is viewed as supporting top-line resilience.

On profitability, raw material prices and SG&A were constraints on Q2 2026 operating profit, and the trend in these two cost lines is the first item to check in upcoming results.

With Q3 2026 operating profit down to KRW 9.82 billion, whether quarterly operating profit recovers to prior-quarter levels from Q4 onward is the key variable.

On an annual basis, the next regular report is the 2026 annual report, where full-year sales and operating margin can be compared with KRW 317.3 billion and 17.0% in 2025. If raw material prices change direction, room for pricing decisions may also shift.

Whether the share of top-tier lines such as Royal Ace keeps expanding after 2026 is the product mix point to verify.

07

Valuation

PER
6.4×
PBR
0.4×
ROE
7.0%
EPS
₩4,951
BPS
₩72,506
Dividend per share
—

Valuation multiples change daily with the share price. The price-to-book ratio has stayed well below 1x over the last five quarters, which means the share price sits low relative to the KRW 748.4 billion of parent-owned equity at year-end 2025.

The price-to-earnings level can be read against the last four quarters of parent net profit totaling KRW 52.3 billion, but because profit has fallen since the 2024 peak, the meaning of the multiple depends on whether earnings recover.

The 2024 dividend yield was above the average of the KOSDAQ general manufacturing group, and dividend capacity is supported by a debt ratio of 9.3% at year-end 2025.

The stock trades at a discount to net asset value rather than at a premium, but the fall in Q3 2026 operating profit after the Q2 peak remains a variable in interpreting the multiple.

Over several years, operating profit rose to KRW 66.2 billion in 2024 and then fell to KRW 54.1 billion in 2025, so whether profit turns up again is the benchmark for interpreting valuation. A single multiple is not enough to judge the level, so earnings direction and asset base should be read together.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-13

08

Bull factors

Premium mix and price resilience

The share of top-tier mattresses, including Royal Ace, expanded to 4.2% of sales in 2024. First-half 2026 average domestic bed selling price rose 4.2% to KRW 2.014 million, and bed sales grew 7.2% over the same period. The company said more customers buy frames and mattresses as a set, improving overall brand profitability.

Financial capacity and cash generation

Year-end 2025 total equity was KRW 748.4 billion and total liabilities were KRW 70 billion, a 9.3% debt ratio. Operating cash flow rose from KRW 50.7 billion in 2022 to KRW 75.1 billion in 2024 and was KRW 51.5 billion in 2025. The light debt structure widens room to keep investing in stores and returning cash to shareholders.

Experience stores and brand strategy

The ACE SQUARE experience format had 54 locations as of early 2025, and 10 stores were opened or renovated in 2025. Operating profit rose 16.1% to KRW 66.2 billion in 2024, reported as a rebound after three years of decline. The in-store try-before-buy model supports sales of higher-priced products.

09

Bear factors

Sharp Q3 profit decline

Q3 2026 operating profit was KRW 9.82 billion, down 40.9% from the prior quarter and down 20.1% year on year. Parent profit fell to KRW 2.97 billion, down 86.8% from the prior quarter. Profit declines overlapping with two consecutive quarters of falling sales are the main bearish factor.

Cost pressure and raw materials

In Q2 2026, SG&A rose 17.5% and raw material prices increased, so operating profit fell 1.7% year on year. Costs offset the benefit of higher average prices, limiting the margin improvement. With beds at 89.3% of sales, cost shocks have a large effect on the whole business.

Sensitivity to housing-related demand

Sales fell 11.5% in 2023, and the company linked the decline to weak moving and interior demand. Sales fell 2.7% in 2025 and operating margin dropped to 17.0%. Because the 2024 rebound relied on premium products and store strategy, whether the same effect holds if external demand weakens remains uncertain.

10

Risk factors

Linkage to housing transactions and moving demand

Beds are tied to newlywed purchases, moving and interior demand. Weak moving and interior demand was cited for the 2023 sales decline. If housing transactions slow, replacement and new purchases could fall together, so demand should be tracked each quarter.

Raw material and SG&A burden

In Q2 2026, higher raw material prices and a 17.5% rise in SG&A led to lower operating profit. Q3 2026 showed the cost burden again as operating profit fell sharply. If costs rise and price increases are limited, margins could come under further pressure.

Product concentration and pricing policy

With beds at 89.3% of sales, demand shifts in a single product line feed directly into company results. Because the company has long held prices, whether it adjusts prices if costs rise remains a variable. Whether relative price competitiveness holds while major rivals raise prices is also a point to verify.

11

What to watch next

  1. Around January 2027 (expected)

    Release of Q4 and full-year 2026 preliminary results. The key checks are whether the Q3 operating profit decline continues into Q4 and how full-year sales compare with KRW 317.3 billion in 2025.

  2. Late March 2027 (statutory deadline)

    Filing of the 2026 annual report. The points to check are the full-year SG&A and raw material cost structure, plus changes in the debt ratio and operating cash flow.

  3. Around the March 2027 annual general meeting (expected)

    Decision and form of the 2026 year-end dividend. The point to check is how shareholder returns move alongside the earnings trend.

  4. Around May 15, 2027 (statutory deadline)

    Q1 2027 quarterly report. The point to check is the quarterly trend against the KRW 85 billion Q1 2026 sales peak, and the SG&A growth rate on the same basis.

12

Overall view

AceBed is a bed-focused company, with beds at 89.3% of first-half 2026 sales, and its premium mix and price resilience are visible in 7.2% growth in bed sales and a 4.2% rise in average selling prices.

Financially, the debt ratio was 9.3% at year-end 2025 and operating cash flow has stayed in the tens of billions of won range. On the other side, annual operating profit fell from KRW 66.2 billion in 2024 to KRW 54.1 billion in 2025, and Q3 2026 operating profit dropped 40.9% from the prior quarter to KRW 9.82 billion.

Sales have declined for two consecutive quarters since the Q1 2026 peak, and in Q2 higher SG&A and raw material prices constrained profit. Sensitivity to housing transactions and moving demand also remains a variable.

Because bullish and bearish factors coexist, the next items to confirm are whether quarterly operating profit recovers from Q4 onward and what the cost structure looks like in the 2026 annual report.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. news.nate.com
  2. inews24.com
  3. v.daum.net
  4. comp.fnguide.com
  5. newspim.com
  6. edaily.co.kr
  7. simplywall.st
  8. news1.kr
  9. edaily.co.kr
  10. etoday.co.kr
  11. biz.heraldcorp.com
  12. m.news.nate.com
  13. m.news.nate.com
  14. sedaily.com
  15. thereport.co.kr
  16. hankooki.com
  17. m.ekn.kr
  18. comp.fnguide.com

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis